Syndax Announces Participation in November Investor Conferences
Hand-out
Press Releases
Syndax Pharmaceuticals, Inc.  
November 1, 2024

Syndax Announces Participation in November Investor Conferences

WALTHAM, Mass., Nov. 1, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive

avatar profile Olean Times Herald

Olean Times Herald


Local & Social